Kenvue KVUE · USD
Consumer Staples · Personal Care Products · US listing · 🇺🇸 United States
S&P 500
19.31
-1.28%
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$15.12bn
FY2019FY2025
Net income
$1.47bn
FY2019FY2025
Free cash flow
$1.72bn
FY2019FY2025
Shareholders' equity
$10.77bn
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $15.12bn | $15.46bn | $15.44bn | $14.95bn | $15.05bn | $14.47bn | $14.32bn |
| Gross profit | $8.79bn | $8.96bn | $8.64bn | $8.29bn | $8.42bn | $7.85bn | $7.66bn |
| Research and development | $382.0m | — | $399.0m | $375.0m | $355.0m | $320.0m | $391.0m |
| Operating income | $2.70bn | $1.84bn | $2.51bn | $2.67bn | $2.92bn | −$979.0m | $1.85bn |
| Net income | $1.47bn | $1.03bn | $1.66bn | $2.06bn | $2.08bn | −$879.0m | $1.44bn |
| Diluted earnings per share | 0.77 | 0.53 | 0.87 | 1.20 | 1.10 | -0.47 | 0.76 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | $27.08bn | $25.60bn | $27.85bn | $27.32bn | $27.93bn | $29.18bn | — |
| Cash and short-term investments | $1.06bn | $1.07bn | $1.38bn | $1.23bn | $740.0m | $618.0m | — |
| Total liabilities | $16.31bn | $15.93bn | $16.64bn | $7.35bn | $7.53bn | $10.82bn | — |
| Debt | $8.39bn | $8.53bn | $8.29bn | $8.96bn | $47.0m | $160.0m | — |
| Shareholders' equity | $10.77bn | $9.67bn | $11.21bn | $19.97bn | $20.40bn | $18.36bn | — |
| Shares outstanding | 1,920m | 1,929m | 1,915m | 1,717m | 1,889m | 1,889m | 1,889m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | $2.20bn | $1.77bn | $3.17bn | $2.52bn | $334.0m | $3.40bn | $3.00bn |
| Capital spending | −$475.0m | −$434.0m | −$469.0m | −$375.0m | −$295.0m | −$229.0m | −$289.0m |
| Free cash flow | $1.72bn | $1.33bn | $2.70bn | $2.15bn | $39.0m | $3.17bn | $2.71bn |
| Dividends paid | −$1.58bn | −$1.55bn | −$14.55bn | — | — | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.96bn | $3.91bn | $3.78bn | $3.76bn | $3.84bn | $3.74bn | $3.66bn | $3.90bn |
| Gross profit | $2.30bn | $2.30bn | $2.14bn | $2.24bn | $2.28bn | $2.18bn | $2.08bn | $2.28bn |
| Operating income | $699.0m | $855.0m | $825.0m | $728.0m | $763.0m | $630.0m | $558.0m | $682.0m |
| Net income | $456.0m | $474.0m | $330.0m | $398.0m | $420.0m | $322.0m | $293.0m | $383.0m |
| Diluted earnings per share | 0.24 | 0.25 | 0.17 | 0.21 | 0.22 | 0.17 | 0.15 | 0.20 |
| Cash from operations | $688.0m | $489.0m | $854.0m | $294.0m | $621.0m | $428.0m | $793.0m | $249.0m |
| Capital spending | −$138.0m | −$139.0m | −$110.0m | −$98.0m | −$88.0m | −$179.0m | −$132.0m | −$59.0m |
| Free cash flow | $550.0m | $350.0m | $744.0m | $196.0m | $533.0m | $249.0m | $661.0m | $190.0m |
| Total assets | $26.73bn | $26.85bn | $27.08bn | $27.25bn | $27.13bn | $26.26bn | $25.60bn | $26.93bn |
| Cash and short-term investments | $1.11bn | $1.07bn | $1.06bn | $1.14bn | $1.07bn | $1.06bn | $1.07bn | $1.06bn |
| Debt | $8.48bn | $8.66bn | $8.39bn | $8.22bn | $7.86bn | $7.98bn | $7.86bn | $7.94bn |
| Shareholders' equity | $10.55bn | $10.61bn | $10.77bn | $10.63bn | $10.73bn | $10.05bn | $9.67bn | $10.64bn |
Financial ratios
Data as of 20 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 58.1% | 58.0% | 56.0% | 55.4% | 55.9% | 54.2% | — |
| Operating margin | 17.9% | 11.9% | 16.3% | 17.9% | 19.4% | 20.7% | — |
| Net margin | 9.7% | 6.7% | 10.8% | 13.8% | 13.8% | -6.1% | — |
| Return on equity | 13.7% | 10.7% | 14.8% | 10.3% | 10.2% | -4.8% | — |
| Return on assets | 5.4% | 4.0% | 6.0% | 7.6% | 7.4% | -3.0% | — |
| Free cash flow yield | 7.8% | 6.4% | 10.6% | 9.4% | 1.9% | — | — |
| Revenue growth | -2.1% | 0.1% | 3.3% | -0.7% | 4.1% | 1.0% | — |
| Earnings growth | 42.7% | -38.1% | -19.4% | -0.7% | -336.4% | -161.3% | — |
| Current ratio | 0.96x | 0.96x | 1.12x | 1.50x | 1.22x | 0.61x | — |
| Debt to equity | 0.78x | 0.88x | 0.74x | 0.45x | 0.00x | 0.01x | — |
| Equity ratio | 39.8% | 37.8% | 40.3% | 73.1% | 73.0% | 62.9% | — |
| Interest coverage | 7.13x | 4.27x | 7.02x | — | — | — | — |
| R&D as a share of sales | 2.5% | — | 2.6% | 2.5% | 2.4% | 2.2% | 2.7% |
| Buybacks as a share of market value | 0.5% | -0.7% | -11.6% | 9.1% | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 0.4% | 0.9% | — |
| Operating income | 0.4% | — | — |
| Net income | -10.7% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 58.0% | 56.9% | 56.3% | — |
| Operating margin | 14.9% | 16.0% | 12.9% | — |
| Net margin | 8.2% | 10.2% | 8.2% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Price to earnings | 22.5 | 40.0 | 24.8 |
| Price to sales | 2.2 | 2.7 | 2.7 |
Market value over time
31 May 2023 to 18 Sept 2026, in USD
$43.05bn$34.25bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Return | -21% | 0% | -20% |
Dividends and splits
Per share, in the currency the company pays
Paid for 3 years. Last went ex-dividend on 12 Aug 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Paid in the year | 0.625 | 0.825 | 0.81 | 0.40 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.